Increased Incidence of COVID-19 Infection in Atopic Dermatitis Patients: A Real-World Cohort Study With Risk Factor...

Area of Science:

• Dermatology and Infectious Diseases

Background:

• Atopic dermatitis (AD) is a prevalent chronic inflammatory skin condition.
• The COVID-19 pandemic highlighted the need to understand infection risks in various patient groups.
• The relationship between AD and COVID-19, including risk factors, requires further investigation.

Purpose of the Study:

• To investigate the association between atopic dermatitis and COVID-19 infection.
• To identify risk factors for COVID-19 infection in patients with atopic dermatitis.

Main Methods:

• Utilized the TriNetX Research Network for data analysis.
• Employed logistic regression to calculate odds ratios (OR) for COVID-19 infection in AD patients.
• Compared infection rates and risk factors between AD patients and a control group.

Main Results:

• Atopic dermatitis patients exhibited significantly higher odds of COVID-19 infection.
• Younger individuals (≤20 years) with AD had lower odds of COVID-19 infection compared to older groups.
• Comorbidities such as hypertension, diabetes, asthma, ischemic heart disease, and obesity increased COVID-19 infection odds in AD patients.
• Dupilumab treatment was associated with lower COVID-19 infection odds compared to certain corticosteroids.

Conclusions:

• Atopic dermatitis is linked to an increased risk of COVID-19 infection across all demographics.
• Specific comorbidities significantly elevate COVID-19 risk in AD patients.
• Dupilumab may offer a protective effect against COVID-19 infection in AD patients compared to traditional steroid treatments.